|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.378 SEK | +0.29% |
|
+4.87% | -30.05% |
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 06-30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
| Market Cap | 204M 21.15M 18.5M 17.06M 15.79M 29.96M 2.02B 30.46M 80.1M 991M 79.4M 77.68M 3.43B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 204M 21.15M 18.5M 17.06M 15.79M 29.96M 2.02B 30.46M 80.1M 991M 79.4M 77.68M 3.43B | EV / Sales 2026 * |
2x | EV / Sales 2027 * | 1.44x |
| Free-Float |
38.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IRLAB Therapeutics AB
| 1 day | +0.29% | ||
| 1 week | +4.87% | ||
| Current month | +11.13% | ||
| 1 month | +11.13% | ||
| 3 months | -7.52% | ||
| 6 months | -31.10% | ||
| Current year | -30.05% |
| 1 week | 1.27 |  | 1.4 |
| 1 month | 1.17 | | 1.4 |
| Current year | 1.17 | | 2.14 |
| 1 year | 1.17 | | 3.7 |
| 3 years | 1.17 | | 20.2 |
| 5 years | 1.17 | | 81.8 |
| 10 years | 1.17 | | 110 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 31/07/2024 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 31/12/2012 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 31/12/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 31/12/2015 |
| Chairman | 73 | 06/05/2020 | |
| Chairman | 68 | 19/02/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-30 | Buy | Chairman | 31,000 | 38.8588% | ||
| 06-30 | Buy | Chief Technology Officer | 4,016,742 | 5,035.0256% | ||
| 06-30 | Buy | Chief Executive Officer | 183,858 | 230.4678% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.29% | +4.87% | -62.14% | -83.03% | 20.99M | |
| -0.31% | -0.05% | +54.19% | +167.75% | 1,084B | |
| -1.71% | -1.63% | +65.57% | +62.21% | 634B | |
| -1.55% | -4.94% | +30.19% | +84.52% | 447B | |
| +0.18% | -1.76% | +29.04% | +26.48% | 330B | |
| -6.22% | -8.14% | +28.87% | +31.18% | 295B | |
| -1.27% | -2.91% | +27.42% | +44.91% | 285B | |
| -0.93% | -3.57% | -27.74% | -39.70% | 218B | |
| -1.52% | -3.39% | +21.91% | +60.85% | 199B | |
| -1.01% | +2.32% | +18.62% | +77.46% | 169B | |
| Average | -1.39% | +3.33% | +18.59% | +43.26% | 365.99B | |
| Weighted average by Cap. | -1.31% | +2.48% | +38.57% | +83.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 102M 10.56M 9.24M 8.52M 7.88M 14.96M 1.01B 15.21M 39.98M 495M 39.64M 38.78M 1.71B | 142M 14.68M 12.84M 11.84M 10.96M 20.79M 1.4B 21.14M 55.59M 688M 55.1M 53.91M 2.38B |
| Net income | -32.6M -3.37M -2.95M -2.72M -2.52M -4.78M -322M -4.86M -12.78M -158M -12.67M -12.39M -548M | 33.3M 3.45M 3.02M 2.78M 2.57M 4.88M 329M 4.96M 13.05M 162M 12.94M 12.66M 560M |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | SEK 1.378 | +0.29% | 169,121 |
| 08/07/26 | SEK 1.374 | -1.43% | 635,257 |
| 07/07/26 | SEK 1.394 | +6.41% | 744,473 |
| 06/07/26 | SEK 1.310 | +1.55% | 662,310 |
| 03/07/26 | SEK 1.290 | -1.83% | 319,074 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IRLAB A Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
